tgoop.com/CIP_USERN/434
Last Update:
Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article
New paper by CIP Members
๐ART significantly lowered AIDS-defining malignancies to a nadir, however, Non-AIDS defining cancers are on the rise.
๐It is hard to make HIV/AIDS vaccines/drugs because of the high mutation rate to a lack of proof-reading functions.
๐The new ART drugs like Ibalizumab and Pro 140 hold the future landscape of HIV management.
๐Combinations of ART immunotherapy and cancer immunotherapy drugs offer a glaring promise for treating malignancies in PLWH.
๐More PLWH with cancers should be included in studies to advance understanding of the effects of new interventions in them.
๐More at: https://authors.elsevier.com/a/1eWBv5aRFnc0q9
@cip_usern
@usern_IntGrp
@usern_net
BY CIP, Cancer Immunology Project

Share with your friend now:
tgoop.com/CIP_USERN/434